just two weeks after Merck pulled its painkiller, Vioxx, which is in the same class of drugs as Bextra, from the market because a study showed.
Since the Merck decision, public health advocates and some congressional leaders have asked pointedly.
I also shared with you the perspectives of my and I think it safe to say.
But, on the phone call, when Kim delivered the new, more damaging results, Gilmartin choices were bleak.
A third trial was studying the drug effect on colon cancer was also underway.
